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Glucose-stimulated insulin release from rodent pancreatic B-cells is thought to be initiated by the closing 
of ATP-sensitive K+ channels in the plasma membrane as a consequence of glucose metabolism. We have 
identified an ATP-sensitive K’ channel in membrane patches excised from human B-cells which is similar 
to that found in rodent B-cells in conductance, kinetics, ATP sensitivity and its inhibition by sulphonylureas. 
In man, the ATP-sensitive K+ channel may also have a central role in glucose-stimulated insulin secretion 
and may be (linked to) the receptor for the hypoglycemic sulphonylureas. 
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1. INTRODUCTION 
The recent application of patch-clamp tech- 
niques to isolated pancreatic B-cells has contri- 
buted to our understanding of the mechanism by 
which glucose regulates insulin secretion, These 
studies have shown that the ATP-sensitive K” 
channel is the major determinant of the B-cell 
resting membrane potential in glucose-free solu- 
tion [ 1,2]. In response to an increase in the external 
glucose concentration the channel closes, produc- 
ing a depolarisation of the B-cell which leads to in- 
creased entry of Ca2+ into the cell and thereby 
insulin secretion [ 1,2]. The ATP-sensitive K+ chan- 
nel may also be the site of action of the 
sulphonylureas, drugs used clinically to increase 
insulin secretion in type II diabetics, because in 
both mouse B-cells [3] and the B-cell line CRC-G1 
[4] these drugs block K+ fluxes through the ATP- 
sensitive K+ channel. 
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To date, all such studies have been carried out 
using B-cells derived from species other than man. 
We report here evidence for the presence of ATP- 
sensitive K+ channels in the membranes of human 
pancreatic B-cells and for their inhibition by the 
sulphonylurea tolbutamide. 
2. MATERIALS AND METHODS 
Human pancreases were obtained from nor- 
moglycaemic, heart-beating cadaver organ donors 
(with permission) and islets isolated by collagenase 
digestion [5]. The secretory responses of human 
islets prepared in this way have been reported 
elsewhere 161. After overnight tissue culture the 
islets were dispersed into single cells, plated onto 
glass coverslips and maintained in short-term 
tissue culture. 
The following criteria indicate that our isolation 
methods yield viable human B-cells, (i) Isolated 
islets have low rates of basal insulin release and 
respond to glucose with a dose-dependent increase 
in insulin secretion and glucose oxidation [6]. (ii) 
Isolated single cells which were not in good condi- 
tion were easily identifiable by the granulated ap- 
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pearance of their cytoplasm, by their fragility (the 
patch membrane would spontaneously rupture to 
yield the whole-cell configuration) and by the oc- 
currence of a large conductance (100 pS) K+ chan- 
nel at the resting potential in cell-attached patches. 
Such cells were not used in the present studies. The 
results we describe here were obtained from 6 suc- 
cessful preparations of human isolated B-cells (out 
of a total of 10). 
Standard patch-clamp methods [7] were used to 
record single-channel currents from celI-attached 
or excised inside-out patches of plasma membrane. 
Full details of our recording system are given 
elsewhere [8]. The patch pipette was filled with 
(mM): 140 KCl, 5 CaCl2, 5 MgS04, 5 NaHepes 
(pH 7.4). For cell-attached recordings the bath 
contained an extracellular solution (mM): 5 KCl, 
135 NaCl, 5 CaC12,5 MgS04,5 NaHepes (pH 7.4). 
For inside-out patches the bath contained an in- 
tracellular solution (mM): 107 #Cl, 2 or 5 MgS04, 
1 CaC12, 11 EGTA + 11 Hepes (stock solution 
titrated to neutrality with KOH; total [K’]i about 
135 mM); pH 7.2, pCa = 8.0. NazATP, KADP 
(Boehringer) or tolbutamide (Sigma) were added as 
indicated. A 1 M stock solution of K-tolbutamide 
was made by dissolving the drug in 1 M KOH. In- 
tracellular solutions were exchanged using a rapid 
flow method [9]. All experiments were carried out 
at room temperature (20-23 “C). 
3. RESULTS 
Currents flowing through single ATP-sensitive 
K+ channels recorded at -60 mV from an inside- 
out membrane patch excised from a human B-cell 
are illustrated in fig.lA. In this configuration the 
cytoplasmic membrane surface is exposed to the 
bath solution. As shown in fig. 1 A, the addition of 
1 mM ATP to the intracellular (bath) solution 
substantially inhibited channel activity, indicating 
that the channel is ATP-sensitive. Inhibition was 
reversed when ATP was removed (not shown). 
This result was observed in each of 4 patches (2 
preparations). 
The relationship between the potential across the 
patch membrane and the amplitude of the single- 
channel current is given in fig.lB. Single-channel 
currents reversed at approx. 0 mV, as expected for 
a K’-selective channel exposed to symmetrical I<+ 
concentrations. Under these conditions, the single- 
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Fig. 1. (A) ATP inhibition of single K+ channel currents. 
Single-channel currents recorded at a membrane 
potential of -60 mV from an inside-out patch of 
human B-cell membrane exposed to intracellular 
solution before (above) and after (below) the addition of 
1 mM ATP. The number of channels open is indicated 
to the right of each trace. (B) Mean current-voltage 
relation of the ATP-sensitive K+ channel. Abscissa: 
membrane potential (mV); ordinate: single-channel 
current amplitude (PA). The symbols refer to different 
cells (n = 4); (0) cell illustrated in A. The lines are fitted 
using a least-squares method and have slopes of 64 pS 
(at negative potentials; correlation coefficient, 0.96) and 
29 pS (at positive potentials). The currents reverse at an 
extrapolated potential of - 2 mV. 
channel conductance measured for inward currents 
was 64 pS, close to that found for ATP-sensitive 
channels in other cells [ 1,2, IO, 1 I]. 
The kinetics of the ATP-sensitive K+ channel 
qualitatively resemble those reported for rodent B- 
cells [ 1,2] in consisting of bursts of channel open- 
ings separated by long interburst intervals (figs 
l-4). At least two closed states are therefore in- 
dicated. Fig.1 further suggests that ATP reduces 
channel activity by decreasing the number of open- 
ings per burst. No effect on the amplitude of the 
single channel currents was observed. 
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The sulphonylureas constitute a selective blocker 
of ATP-sensitive K+ channels [3]. Therefore, we 
tested the ability of these drugs to block ATP- 
sensitive K+ currents in human B-cells (2 patches 
from different preparations). Tolbutamide (1 mM) 
applied to the intracellular membrane surface 
rapidly produced a complete block of single- 
channel currents (fig.2). Channel activity only par- 
tially recovered on removal of the drug; this does 
not imply that the effect of tolbutamide is only 
partly reversible, however, as we found channel ac- 
tivity runs down with time in isolated patches from 
human B-cells (as is found for other ATP-sensitive 
K+ channels [12,13]). In an attempt to avoid the 
problem of rundown, we also tested tolbutamide 
on an inside-out patch in the presence of 0.1 mM 
ATP + 0.1 mM ADP (fig.3). Stable channel activi- 
ty was found in this control solution; others have 
also reported that ATP is required to maintain 
channel activity in B-cells [3,11]. In the presence of 
these concentrations of ATP and ADP, 1 PM 
tolbutamide was ineffective, 10pM almost, and 
100 PM totally, inhibited channel activity. These 
results were fully reversible and could be repeated 
several times in the same patch. These preliminary 
observations are consistent with the dose-response 
curve reported for mouse B-cells where half- 
maximal inhibition is produced by ~,uM 
tolbutamide [3]. 
ATP-sensitive K+ channel currents were also 
recorded from cell-attached patches on intact cells 
exposed to glucose-free solution (fig.4A). The 
mean conductance, measured over the linear 
region of the current-voltage relation between 
pipette potentials of 80 to -20 mV, was 56 pS (4 
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Fig.2. Effect of tolbutamide on single ATP-sensitive K+ 
channel currents. Single-channel currents were recorded 
at - 60 mV from inside-out patches excised from human 
B-cells. Intracellular solution f 1 mM tolbutamide as 
indicated. The lower trace was obtained 35 s after the 
upper. 
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Fig.3. Effect of different tolbutamide concentrations on 
ATP-sensitive K+ channel currents. Single-channel 
currents recorded at - 60 mV from an inside-out patch 
exposed to intracellular solution containing 0.1 mM 
NazATP + 0.1 mM KADP. Tolbutamide was added as 
indicated by the bar. The traces are a continuous 
recording from the same patch. The upward deflections 
of the current trace are artefacts associated with the 
solution exchange [8]. 
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Fig.4. (A) Single-channel currents recorded at the resting 
potential (V, = 0 mV) from a cell-attached patch on a 
human B-cell in standard external solution (no glucose). 
(B) Single-channel current-voltage relation measured 
from cell-attached patches on human B-cells. Abscissa: 
pipette potenial (mV), 0 mV = resting potential; 
ordinate: single-channel current (PA). Symbols indicate 
mean and vertical lines the SE. The number of samples 
at each potential is indicated adjacent to the symbol. 
preparations) similar to that found for the isolated 
patch. Reversal of single-channel currents oc- 
curred at pipette potentials between -45 to 
- 80 mV (mean - 61 + 9 mV; n = 4, 4 prepara- 
tions; EreY was extrapolated in 2 patches). This 
value is somewhat less than that found for rodent 
11 
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B-cells (approx. - 70 mV [1,2]) suggesting that 
either [K+]i is higher in human B-cells or that the 
resting potential is on average around 10 mV more 
positive (i.e. about -60 mV). In healthy cells, 
ATP-sensitive K+ channel currents constituted 
most of the channel activity observed at the resting 
potential but the amount of this activity was very 
variable. We also observed a large conductance K+ 
channel (100 pS) activated at positive membrane 
potentials, similar to that reported in rodent B- 
cells [l]. 
4. DISCUSSION 
The main finding we report here is the presence 
of an ATP-sensitive K+ channel in the membranes 
of human B-cells. This channel was identified from 
its inhibition by millimolar ATP, its conductance, 
permeability to K+, characteristic burst kinetics 
and block by tolbutamide. The dominant activity 
of the ATP-sensitive K+ channel in intact cells ex- 
posed to glucose-free solutions suggests that, as in 
rodents [1,2], this channel may make a major con- 
tribution to the resting membrane K+ permeabili- 
ty. If our preliminary observation that the 
ATP-sensitive K+ channel in human B-cells is in- 
hibited by tolbutamide is confirmed by further ex- 
periments, this might account for the hypoglyc- 
aemic action of the sulphonylureas in man. 
Although the results presented here were ob- 
tained from a relatively few number of patches, we 
felt it important to report them because of the lack 
of any electrophysiological data on human B-cells. 
Our findings provide additional support for the 
view that models of insulin secretion derived from 
rodent islets may be applicable to man. 
It is well established that glucose-stimulated in- 
sulin release is impaired in type II diabetes. Since 
sulphonylureas increase insulin secretion in type II 
diabetes and inhibit the ATP-sensitive K+ channel, 
it may be that the primary lesion in at least some 
type II diabetics is a defect in the regulation of the 
ATP-sensitive K+ channel. Thus it seems possible 
that in these diabetics the ATP-sensitive K+ chan- 
nel may be closed by sulphonylureas but not, as in 
normal subjects, by glucose metabolism. In this 
context it is interesting that futile cycles of ATP 
consumption have been reported for hepatocytes 
isolated from early type II diabetics [14]. We sug- 
gest that, in at least some patients, type II diabetes 
12 
may result from either (i) a failure to generate the 
second messenger (possibly ATP) that links 
metabolic events to channel inhibition or (ii) a 
defect in the channel (or associated control pro- 
teins) which results in an inability to recognise the 
second messenger. Studies using B-cells isolated 
from type II diabetics will be required to test these 
hypotheses. 
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